EXCELLENT News: Nasal Spray PREVENTS SARS-CoV-2 Infection, People Who Don't Use it At Higer Risk of Infection and Higher Risk of Symptoms if Infected

Prospective, Randomized, Double-Blind, Placebo-Controlled Trial show

Finally some excellent news!!!

From Dr. McCullough:

“Balmforth et al, conducted a prospective double-blind, placebo-controlled trial of a xylitol based nasal spray in the prevention of SARS-CoV-2 infection in exposed healthcare workers in two hospitals in Uttar Pradesh, India. Xylitol is known to have anti-infective and anti-inflammatory properties and is used in XLEAR nasal spray and anti-infective chewing gum to prevent dental caries. Balmforth found that SARS-CoV-2 infection confirmed by serology was 71% lower with xylitol compared to placebo [36 cases (13.1%) Vs 97 cases (34.5%); odds ratio [OR] 0.29 (95% CI; 0.18–0.45), p < 0.0001]. Fewer clinical symptoms were also seen in the test group [57 cases (17.6%) vs 112 cases (34.6%); OR 0.40, (95% CI; 0.27–0.59), p < 0.0001]. No harmful effects were associated with xylitol. A smaller study of xylitol nasal spray in mild COVID-19 cases demonstrated that persistent loss of smell may be eliminated with xylitol nasal spray during the acute congestion phase.”

People who do not use XLEAR are 3.45 times more likely to have SARS-CoV-2 infection.

People who were infected who did not use XLEAR are 2.5 times more likely to have symptomatic infection (i.e., bona fide COVID-19)

Read the full article:

Xylitol Nasal Spray Prevents SARS-CoV-2 Infection